Perkins Capital Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,426,300	Closed	-$802K	–	109
2020 Q3	$802K	Buy	+2,426,300	New	+$802K	0.74%	42
2020 Q1	$791K	Sell	2,434,000 -93,000	-4%	-$30.2K	0.96%	40
2019 Q4	$1.77M	Buy	2,527,000 +173,847	+7%	+$122K	1.59%	18
2019 Q3	$1.56M	Buy	2,353,153 +1,760,533	+297%	+$1.17M	1.35%	26
2019 Q2	$984K	Sell	592,620 -27,300	-4%	-$45.3K	0.69%	43
2019 Q1	$1.55M	Buy	619,920 +169,970	+38%	+$425K	1.02%	28
2018 Q4	$1.14M	Buy	449,950 +200,250	+80%	+$509K	0.89%	31
2018 Q3	$1.26M	Hold	249,700	–	–	0.76%	45
2018 Q2	$814K	Sell	249,700 -400	-0.2%	-$1.3K	0.58%	61
2018 Q1	$905K	Buy	+250,100	New	+$905K	0.81%	43